Temasek's Accuron MedTech leads $1.9m pre-series A in Singapore startup Advent Access

Photo: Pixabay

Temasek Holdings’ unit Accuron MedTech has led a S$2.6 million  ($1.9 million) pre-Series A round in Singapore-based startup Advent Access, which is developing a vascular access device for dialysis patients, according to an announcement.

Advent Access, a medtech startup spinoff from A*STAR, aims  to reduce dialysis cost and restore quality of life for kidney failure patients, while tapping into a $90 billion worldwide market.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter